Related Experiment Video
Updated: Jul 15, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Impaired fatty acid metabolism in AKI: experimental evidence - a narrative review
Johanna Gruzla1, Stefan Erfurt1, Benedikt Marahrens1
1Department of Internal Medicine I - Cardiology, Nephrology and Internal Intensive Care Medicine, University Hospital Brandenburg, Brandenburg Medical School (Theodor Fontane), Hochstraße 29, 14770, Brandenburg an der Havel, Germany.
Background:
Acute kidney injury (AKI) is a common and serious complication of hospitalized patients worldwide. In most cases, the syndrome is characterized by dysfunction/structural damage of the tubular epithelial cells. The metabolic feature is a reduction in cellular adenosine triphosphate (ATP) synthesis as a result of decreased fatty acid oxidation. Stabilization of the fatty acid (FA) oxidation process may influence the course of AKI, whether caused by endogenous or exogenous factors. In this narrative review, we discuss experimental evidence on the modulation of fatty acid metabolism in AKI.
Methods:
Narrative review article. The following databases were searched for references: PubMed, Web of Science, Cochrane Library, Scopus. The period lasted from 2010 until May 2026.
Results:
Finally, 16 articles on the modulation of fatty acid metabolism in experimental AKI were identified. Disturbances in the FA oxidation process are associated with an aggravation of renal dysfunction in AKI, and lipids accumulate in the renal tissue itself. The consequences of exogenous fatty acid intake depend on the structural characteristics of the metabolites applied, as well as on the pattern of renal damage and the relevant pathophysiological processes.
Conclusions:
Under certain conditions, adequate fatty acid oxidation may be considered nephroprotective; however, the complexity of the syndrome's pathophysiology must always be taken into account. Distinct fatty acids have the potential to offer therapeutic benefits in AKI cases. However, the efficacy of an FA-based therapeutic approach depends on two main factors: the chemical structure of the substances used and the nature of the underlying kidney disease.
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Acute Kidney Injury I: Introduction
Diabetic Ketoacidosis ll: Pathophysiology
Chronic Pancreatitis II: Pathophysiology
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...